In this issue... Company features, market insight & Aggressive Portfolio III.
Form an Alliance
Recent final results from Alliance Pharma (87.8p) were well received and we believe that the shares could soon hit the 100p level which has only been achieved very briefly in the past. Long term shareholders have been very well rewarded but anyone who has invested over the last three years has seen the shares move broadly sideways and will have had to be fortunate with timing to have seen significant capital growth.
Alliance Pharma is an international healthcare group based in the UK and with…
CONTINUED IN THE FULL NEWSLETTER CLICK TO READ.
